Clinician's guide to human papillomavirus immunology: knowns and unknowns
- 1 June 2009
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 9 (6), 347-356
- https://doi.org/10.1016/s1473-3099(09)70108-2
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific AntibodiesJournal of Virology, 2008
- Cytokine Release in HR-HPV(+) Women without and with Cervical Dysplasia (CIN II and III) or Carcinoma, Compared with HR-HPV() ControlsMediators of Inflammation, 2007
- Neutralization of Human Papillomavirus with Monoclonal Antibodies Reveals Different Mechanisms of InhibitionJournal of Virology, 2007
- Association of cervical cancer with the presence of CD4+regulatory T cells specific for human papillomavirus antigensProceedings of the National Academy of Sciences, 2007
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- High Number of Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes Is Associated with the Absence of Lymph Node Metastases in Patients with Large Early-Stage Cervical CancerCancer Research, 2007
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006
- Human papillomaviruses target the double-stranded RNA protein kinase pathwayJournal of General Virology, 2006
- Keratinocyte-Secreted Laminin 5 Can Function as a Transient Receptor for Human Papillomaviruses by Binding Virions and Transferring Them to Adjacent CellsJournal of Virology, 2006
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 2003